Mulmit

Cullinan Therapeutics, Inc.Cullinan Therapeutics, Inc.

CGEM US

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2022-12-310144,648,000111,214,0002.38
2021-12-3118,943,000-67,954,000-65,570,000-1.52
2020-12-310-60,335,000-51,799,000
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…